European Journal of Chemistry

Synthesis and biological evaluation of shikimic acid derivatives

Main Article Content

Van Hung Nguyen
Van Cuong Pham
Huong Doan Thi Mai
Thanh Nguyen Le
Thi Minh Hang Nguyen
Van Nam Vu
Huu Giap Tran
Thi Thao Do
Wim Dehaen
Van Minh Chau


From shikimic acid, new series of oseltamivir analogues containing either ether sulfur or ether oxygen at C-3 position were prepared and evaluated for their biological activities. This is the first report on synthesis of oseltamivir analogues with ether sulfur at C-3. Except for compounds 4d, 4f, 7c and 7d, the remaining compounds were found to be active against MCF-7, LU-1 and KB cell lines. As oseltamivir had no cytotoxicity against different cell lines such as MCF-7, LU-1, KB, MDCK, MRC-5, VERO, MK and 293, the modification of alkyl groups at C-3 of the oseltamivir ring framework could significantly increase the cytotoxicity for this class of compounds. Loss of neuraminidase inhibition activity of these synthetic oseltamivir analogues suggested that the alkyl ether groups at C-3 should be critical for their anti-neuraminidase activity.

icon graph This Abstract was viewed 2030 times | icon graph Article PDF downloaded 1113 times

How to Cite
Nguyen, V. H.; Pham, V. C.; Mai, H. D. T.; Le, T. N.; Nguyen, T. M. H.; Vu, V. N.; Tran, H. G.; Do, T. T.; Dehaen, W.; Chau, V. M. Synthesis and Biological Evaluation of Shikimic Acid Derivatives. Eur. J. Chem. 2014, 5, 601-606.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Rohloff, J. C.; Kent, K. M.; Postich, M. J.; Becker, M. W.; Chapman, H. H.; Kelly, D. E.; Lew, W.; Louie, M. S.; McGee, L. R.; Prisbe, E. J.; Schultze, L. M., Yu, R. H.; Zhang, L. J. Org. Chem. 1998, 63, 4545-4550.

[2]. Federspiel, M.; Fischer, R.; Hennig, M.; Mair, H. J.; Oberhauser, T.; Rimmler, G.; Albiez, T.; Bruhin, J.; Estermann, H.; Gandert, C.; Göckel, V.; Götzö, S.; Hoffmann, U.; Huber, G.; Janatsch, G.; Lauper, S.; Röckel-Stäbler, O.; Trussardi, R.; Zwahlen, A. G. Org. Process Res. Dev. 1999, 3, 266-274.

[3]. Abrecht, S.; Harrington, P.; Iding, H.; Karpf, M.; Trussardi, R.; Wirz, B.; Zutter, U. Chimia 2004, 58, 621-629.

[4]. Karpf, M.; Trussardi, R. J. Org. Chem. 2001, 66, 2044-2051.

[5]. Harrington, P. J.; Brown, J. D.; Foderaro, T.; Hughes, R. C. Org. Proc. Res. Dev. 2004, 8, 86-91.

[6]. Genovese, S.; Curini, M.; Epifano, F. Phytochemistry 2009, 70, 1082-1091.

[7]. Floss, H. G. Nat. Prod. Rep. 1997, 14, 433-452.

[8]. Kishore, G. M.; Shah, D. M. Annu. Rev. Biochem. 1988, 57, 627-663.

[9]. Zamir, L. O.; Luthe, C. Can. J. Chem. 1984, 62, 1169-1175.

[10]. Sutherland, J. K.; Watkins, W. J.; Snow, G. A.; Davies G. M. U. S. Patent 5 164 382, 1992.

[11]. Davies, G. M.; Barrett-Bee, K. J.; Jude, D. A.; Lehan, M.; Nichols, W. W.; Pinder, P. E.; Thain, J. L.; Watkins, W. J.; Wilson, R. G. Antimicrob. Agents Ch. 1994, 38, 403-406.

[12]. Numata, A.; Iritani, M.; Yamada, T.; Minoura, K.; Matsumura, E.; Yamori, T.; Tsuruo T. Tetrahedron Lett. 1997, 38, 8215-8218.

[13]. Aghil, O.; Bibby, M. C.; Carrington, S. J.; Double, J.; Douglas, K. T.; Phillips, R. M.; Shing, T. K. Anti-cancer Drug Des. 1992, 7, 67-82.

[14]. McConkey, G. A. Antimicrob. Agents Ch. 1999, 43, 175-177.

[15]. Johansson, L.; Liden, G. J. Biotechnol. 2006, 126, 528-545.

[16]. Yamada, T.; Iritani, M.; Ohishi, H.; Tanaka, K.; Minoura, K.; Doi, M.; Numata, A. Org. Biomol. Chem. 2007, 5, 3979-3986.

[17]. Nguyen, Q. C.; Doan, T. M. H.; Le, A. T.; Pham, X. V.; Tran, T. T. T.; Pham, V. C.; Nguyen, V. H. Tap. Chi. Hoa. Hoc. 2006, 44, 745-748.

[18]. Mosmann T. J. Immunol. Methods 1983, 65, 55-63.

[19]. Nie, L. D.; Shi, X. X. Tetrahedron-Asymmetry 2009, 20, 124-129.

[20]. Liang-Deng, N.; Xiao-Xin, S.; Kwang, H. K.; Wei-Dong, L. J. Org. Chem. 2009, 74, 3970-3973.

[21]. Yadav, J. S.; Reddy, B. V. S.; Kumar, G. M.; Murthy, C. V. S. R. Synthetic Commun. 2002, 32, 1797-1802.

[22]. Lew, W.; Escarpe, P. A.; Mendel, D. B.; Sweeny, D. J.; Kim, C. U. Bioorg. Med. Chem. Lett. 1999, 9, 2811-2814.

[23]. Oseltamivir Medical Review. US FDA Center for Drug Evaluation and Research, Application No. 021087, 25 October 1999.

[24]. Kim, C. U.; Lew, W.; Williams, M. A.; Liu, H.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendel, D. B.; Tai, C. Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc. 1997, 119, 681-690.

Supporting Agencies

Vietnam National Foundation for Science and Technology Development (NAFOSTED) and the Research Foundation Flanders (FWO) (Project No, 04/2010).
Most read articles by the same author(s)

Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).